Welcome to CDC stacks | Macrolide-Resistant Mycoplasma pneumoniae, United States1 - 32669 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Macrolide-Resistant Mycoplasma pneumoniae, United States1
Filetype[PDF-574.09 KB]


Details:
No Related Documents.
You May Also Like:
  1. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015
    Personal Author:
    Tanaka, Takaaki; Oishi, Tomohiro; Miyata, Ippei; Wakabayashi, Shoko; Kono, Mina; Ono, Sahoko; Kato, Atsushi; Fukuda, Yoko; Saito, Aki; Kondo, Eisuke; Teranishi, Hideto; Tanaka, Yuhei; Wakabayashi, Tokio; Akaike, Hiroto; Ogita, Satoko; Ohno, Naoki; Nakano, Takashi; Terada, Kihei; Ouchi, Kazunobu;
    Published:
    Oct 2017
    Source:
    Emerg Infect Dis. 23(10):1703-1706.
    Description:
    We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008-2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The preva...
    File Type:
    Filetype[PDF - 1.03 MB]
  2. Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011
    Personal Author:
    Hong, Ki Bae; Choi, Eun Hwa; Lee, Hoan Jong; Lee, Seong Yeon; Cho, Eun Young; Choi, Jae Hong; Kang, Hyun Mi; Lee, Jina; Ahn, Young Min; Kang, Yeon-Ho; Lee, Joon-Ho;
    Published:
    Aug 2013
    Source:
    Emerg Infect Dis. 19(8):1281-1284.
    Description:
    In Korea, Mycoplasma pneumoniae was detected in 255/2,089 respiratory specimens collected during 2000-2011; 80 isolates carried 23S rRNA gene mutations, and 69/123 culture-positive samples with the mutation were resistant to 5 macrolides. During 2000...
    File Type:
    Filetype[PDF - 508.51 KB]
  3. Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011
    Personal Author:
    Eshaghi, AliReza; Memari, Nader; Tang, Patrick; Olsha, Romy; Farrell, David J.; Low, Donald E.; Gubbay, Jonathan B.; Patel, Samir N.;
    Published:
    2013
    Source:
    Emerg Infect Dis. 19(9):1525-1527.
    Description:
    Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associ...
    File Type:
    Filetype[PDF - 376.90 KB]
  4. The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae
    Personal Author:
    Diaz, Maureen H.; Winchell, Jonas M.;
    Published:
    Mar 08 2016
    Source:
    Front Microbiol. 2016; 7.
    Description:
    Over the past decade there have been significant advancements in the methods used for detecting and characterizing Mycoplasma pneumoniae, a common cause of respiratory illness and community-acquired pneumonia worldwide. The repertoire of available mo...
    File Type:
    Filetype[PDF - 904.79 KB]
  5. Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
    Personal Author:
    Averbuch, Diana; Hidalgo-Grass, Carlos; Moses, Allon E.; Engelhard, Dan; Nir-Paz, Ran;
    Published:
    Jun 2011
    Source:
    Emerg Infect Dis. 17(6):1079-1082.
    Description:
    Macrolide resistance in Mycoplasma pneumoniae is often found in Asia but is rare elsewhere. We report the emergence of macrolide-resistant M. pneumoniae in Israel and the in vivo evolution of such resistance during the treatment of a 6-year-old boy w...
    File Type:
    Filetype[PDF - 360.79 KB]